Strumento inattivo

Azioni YM BioSciences Inc.

Azioni

Durata

Periodo

Stile

YM Biosciences : Raises US$80.5 Million from Public Offering	29/02/12
YM Biosciences : Prices $70 Million Public Offering of Common Shares	24/02/12
YM Biosciences : Announces Proposed Public Offering of Common Shares	23/02/12
YM Biosciences : Reports Operational and Financial Results for the Second Quarter of Fiscal 2012	09/02/12
YM Biosciences : Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011	12/12/11

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	+0,17%	42,19 Mrd
MODERNA, INC.	+10,92%	42,24 Mrd
LONZA GROUP AG	+44,30%	40,15 Mrd
CELLTRION, INC.	-6,20%	28,31 Mrd
ICON PUBLIC LIMITED COMPANY	+5,23%	24,63 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-24,79%	18,2 Mrd
MEDPACE HOLDINGS, INC.	+26,69%	12,01 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,13%	11,76 Mrd
UNITED THERAPEUTICS CORPORATION	+6,57%	10,4 Mrd